Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Merck-Gilead first-of-its-kind combo pill scores in 2 HIV trials
A combo pill from Merck and Gilead has succeeded in two phase 3 trials and is set up to become the first oral HIV treatment that can be taken weekly.
Kevin Dunleavy
Jun 9, 2026 11:20am
Gilead's Trodelvy stumbles in first-line NSCLC
Jun 9, 2026 11:14am
Designing an agentic, future‑ready tech roadmap for emerging pharma
Brought to you by
ZS
AstraZeneca reprimanded over LinkedIn likes once again
Jun 9, 2026 6:16am
Pharma marketers face privacy hurdles, turn to omnichannel strategies
Brought to you by
Swoop
The Oral GLP-1 Tracker: Oral Wegovy hits 3M prescription milestone
Jun 8, 2026 4:00pm
